Skip to main navigation Skip to search Skip to main content

Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin As First-Line Therapy in Type 2 Diabetes

  • Patricia Rodriguez
  • , Samuel Gratzl
  • , Ryan Lee
  • , Sarah Gilson
  • , Peter Smits
  • , Nicholas L Stucky
  • , Tyler J Gluckman

Research output: Other contribution

Original languageUndefined/Unknown
StatePublished - May 1 2023

Publication series

NameArticles, Abstracts, and Reports

Cite this